![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 62, Issue 5, 975-982, November 2002
/Aryl Hydrocarbon Receptor Nuclear
Translocator DNA Binding by the 90-kDa Heat-Shock Protein Inhibitor
Radicicol
Department of Life Science, University of Seoul, Seoul, Korea
(E.H., S.M.C., S.Y., Y.C., H.P.); Research Center for Proteineous
Materials and School of Dentistry, Chosun University, Gwangju, Korea
(H.-H.K.); Department of Bioscience and Biotechnology, Institute of
Bioscience, Sejong University, Seoul, Korea (J.H.K., H.J.K., M.-O.L.);
and Department of Environmental and Health Chemistry, College of
Pharmacy, Chung-Ang University, Seoul, Korea (D.K.K.)
Under low oxygen tension, cells increase the transcription of specific
genes involved in angiogenesis, erythropoiesis, and glycolysis.
Hypoxia-induced gene expression depends primarily on stabilization of
the 
subunit of hypoxia-inducible factor-1 (HIF-1), which acts as
a heterodimeric trans-activator with the nuclear protein
known as the aryl hydrocarbon receptor nuclear translocator (Arnt). The
resulting heterodimer (HIF-1/Arnt) interacts specifically with the
hypoxia-responsive element (HRE), thereby increasing transcription of
the genes under HRE control. Our results indicate that the 90-kDa
heat-shock protein (Hsp90) inhibitor radicicol reduces the
hypoxia-induced expression of both endogenous vascular endothelial
growth factor (VEGF) and HRE-driven reporter plasmids. Radicicol
treatment (0.5 µg/ml) does not significantly change the stability of
the HIF-1 protein and does not inhibit the nuclear localization of
HIF-1. However, this dose of radicicol significantly reduces HRE
binding by the HIF-1/Arnt heterodimer. Our results, the first to
show that radicicol specifically inhibits the interaction between the
HIF-1/Arnt heterodimer and HRE, suggest that Hsp90 modulates the
conformation of the HIF-1/Arnt heterodimer, making it suitable for
interaction with HRE. Furthermore, we demonstrate that radicicol
reduces hypoxia-induced VEGF expression to decrease hypoxia-induced angiogenesis.
This article has been cited by other articles:
|
|
 |
|
  F. KOGA, K. KIHARA, and L. NECKERS Inhibition of Cancer Invasion and Metastasis by Targeting the Molecular Chaperone Heat-shock Protein 90 Anticancer Res, March 1, 2009; 29(3): 797 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Toogun, D. C. DeZwaan, and B. C. Freeman The Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities Mol. Cell. Biol., January 1, 2008; 28(1): 457 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy J. Leukoc. Biol., January 1, 2007; 81(1): 15 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Linehan, J. Vasselli, R. Srinivasan, M. M. Walther, M. Merino, P. Choyke, C. Vocke, L. Schmidt, J. S. Isaacs, G. Glenn, et al. Genetic Basis of Cancer of the Kidney: Disease-Specific Approaches to Therapy Clin. Cancer Res., September 15, 2004; 10(18): 6282S - 6289S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Powis and L. Kirkpatrick Hypoxia inducible factor-1{alpha} as a cancer drug target Mol. Cancer Ther., May 1, 2004; 3(5): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Teng, Y.-Y. Chen, Y.-N. Su, P.-C. Chou, Y.-C. Chiang, S.-F. Tseng, and K.-J. Wu Direct Activation of HSP90A Transcription by c-Myc Contributes to c-Myc-induced Transformation J. Biol. Chem., April 9, 2004; 279(15): 14649 - 14655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, T. Schmid, R. Frank, and B. Brune PI3K/Akt Is Required for Heat Shock Proteins to Protect Hypoxia-inducible Factor 1{alpha} from pVHL-independent Degradation J. Biol. Chem., April 2, 2004; 279(14): 13506 - 13513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hopfl, O. Ogunshola, and M. Gassmann HIFs and tumors--causes and consequences Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R608 - R623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C Chi and J. S Karliner Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors Cardiovasc Res, February 15, 2004; 61(3): 437 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-x. Chen, M. L. Lawrence, G. Cunningham, B. W. Christman, and B. Meyrick HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium J Appl Physiol, February 1, 2004; 96(2): 612 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Tschan, K. M. Fischer, V. S. Fung, F. Pirnia, M. M. Borner, M. F. Fey, A. Tobler, and B. E. Torbett Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns J. Biol. Chem., October 31, 2003; 278(44): 42750 - 42760. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
